Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion type Assertion NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_head.
- NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion description "[This validated assay is being applied to approximately 10, 000 lymph nodes in a prospective trial to define the sensitivity of Guanylyl cyclase C (GCC) qRT-PCR for staging patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_provenance.
- NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion evidence source_evidence_literature NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_provenance.
- NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion SIO_000772 16899600 NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_provenance.
- NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion wasDerivedFrom lhgdn-20090331 NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_provenance.
- NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_assertion wasGeneratedBy ECO_0000203 NP107185.RAqv6UGINgEgLXyQG8HHa2LuKZTsSN8FNyJMy5BpTXOzw130_provenance.